Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview

Michael "Mike" Pearson, chairman and chief executive officer of Valeant Pharmaceuticals International Inc., pauses during a Bloomberg Television interview in New York, U.S., on Wednesday, April 23, 2014. With his $45.7 billion bid for Allergan Inc., Pearson is pulling the credit rating of Canada's most indebted junk bond issuer closer to investment grade while attempting the biggest takeover in the country's history. Photographer: Scott Eells/Bloomberg via Getty Images
Michael "Mike" Pearson, chairman and chief executive officer of Valeant Pharmaceuticals International Inc., pauses during a Bloomberg Television interview in New York, U.S., on Wednesday, April 23, 2014. With his $45.7 billion bid for Allergan Inc., Pearson is pulling the credit rating of Canada's most indebted junk bond issuer closer to investment grade while attempting the biggest takeover in the country's history. Photographer: Scott Eells/Bloomberg via Getty Images
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
ライセンスの購入
どんな用途に素材を使えますか？
￥38,500
JPY

詳細

制限:
商業目的またはプロモーション目的で使用する場合は、ゲッティ イメージズのオフィスへお問い合わせください。For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
クレジット:
Bloomberg / 寄稿者
報道写真番号:
486251735
コレクション:
Bloomberg
作成日:
2014年04月23日(水)
アップロード日：
ライセンスタイプ:
ライツマネージ
リリース情報:
リリースされていません。 詳細情報
ソース:
Bloomberg
オブジェクト名:
VALEANT PERSHING